Glyko Biomedical
This article was originally published in The Gray Sheet
Executive Summary
Approved for listing on the National Association of Securities Dealers' OTC bulletin board effective Nov. 18. The shares have been trading on the Toronto Stock Exchange since the firm's initial public offering in 1992. Novato, California-based Glyko, which manufactures carbohydrate instrument and reagent systems based on its FACE fluorophore-assisted carbohydrate electrophoresis technology, "believes that the needs of its U.S. shareholders will be more conveniently served" by the new listing.